{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T21:26:40Z","timestamp":1762032400600},"reference-count":14,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2002,11,6]],"date-time":"2002-11-06T00:00:00Z","timestamp":1036540800000},"content-version":"vor","delay-in-days":97,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contact Dermatitis"],"published-print":{"date-parts":[[2002,8]]},"abstract":"<jats:p>Nonsteroidal anti\u2010inflammatory drugs (NSAIDs) are among those therapeutics most frequently causing pseudoallergic and sometimes allergic cutaneous adverse reactions. Coxibs preferentially inhibiting cyclooxygenase\u20102 are increasingly propagated as alternatives in NSAID\u2010sensitive patients. We evaluated the tolerability of celecoxib in NSAID\u2010sensitive patients. In 14 consecutive patients (6 males, 8 females, age 18\u201372\u2003years), scratch and patch tests with homogenized Celebrex\u00ae were performed, followed by single\u2010blind, placebo\u2010controlled oral provocation (maximal single dose: 200\u2003mg; cumulative dose: 350\u2003mg). 8 of the first 10 patients showed erythematous reactions to celecoxib on patch testing after 2\u2003days with decrescendo kinetics between then and day 3. 9 patients with no history of NSAID intolerance showed similar reactions. When the patch tests were repeated with homogenized Celebrex\u00ae at final concentrations of 5% and 10% in petrolatum, no reaction was observed in any patient. Subsequent oral provocation was tolerated without adverse effects by all individuals. We conclude that patch tests with high concentrations of celecoxib cause irritant reactions and do not correlate with the outcome of oral provocation tests. Therefore, these tests should be performed with lower concentrations of celecoxib (Celebrex\u00ae). Celecoxib itself seems to be a valuable alternative drug in NSAID\u2010sensitive patients.<\/jats:p>","DOI":"10.1034\/j.1600-0536.2002.470208.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T13:04:27Z","timestamp":1047387867000},"page":"100-102","source":"Crossref","is-referenced-by-count":26,"title":["Positive patch test reactions to celecoxib may be due to irritation and do not correlate with the results of oral provocation"],"prefix":"10.1111","volume":"47","author":[{"given":"M.","family":"Kleinhans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Linzbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Zedlitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. \u2010H.","family":"Boehncke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,11,6]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.13.7563"},{"key":"e_1_2_5_3_2","first-page":"6","article-title":"The discovery and function of COX\u20102","volume":"24","author":"Needleman P","year":"1997","journal-title":"J Rheumatol"},{"key":"e_1_2_5_4_2","first-page":"2","article-title":"Scientific rationale for specific inhibition of COX\u20102","volume":"25","author":"Bolten W W","year":"1998","journal-title":"J Rheumatol"},{"key":"e_1_2_5_5_2","first-page":"821","volume-title":"Proceedings of the XVth European Congress of Allergy and Clinical Immunology.","author":"Dahlen B","year":"1996"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.26.15810"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200059040-00017"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200059060-00001"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07922-9"},{"key":"e_1_2_5_10_2","first-page":"1338","article-title":"Analysis of the effect of COX\u20102 specific inhibitors and recommendations for their use in clinical practise","volume":"27","author":"Lipsky P E","year":"2000","journal-title":"J Rheumatol"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-12640"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)62017-0"},{"key":"e_1_2_5_13_2","first-page":"203","article-title":"Celecoxib induced toxiderma with positive patch\u2010test","volume":"129","author":"Verbeiren S","year":"2002","journal-title":"Ann Dermatol Venerol"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2000.110926"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200101113440215"}],"container-title":["Contact Dermatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0536.2002.470208.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0536.2002.470208.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1600-0536.2002.470208.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T20:15:49Z","timestamp":1698783349000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1600-0536.2002.470208.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["10.1034\/j.1600-0536.2002.470208.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1600-0536.2002.470208.x","archive":["Portico"],"relation":{},"ISSN":["0105-1873","1600-0536"],"issn-type":[{"value":"0105-1873","type":"print"},{"value":"1600-0536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,8]]}}}